1. Home
  2. MCRB vs BZUN Comparison

MCRB vs BZUN Comparison

Compare MCRB & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$17.19

Market Cap

162.7M

Sector

Health Care

ML Signal

HOLD

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.95

Market Cap

168.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCRB
BZUN
Founded
2010
2007
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
162.7M
168.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
MCRB
BZUN
Price
$17.19
$2.95
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$14.33
$4.20
AVG Volume (30 Days)
323.3K
189.8K
Earning Date
11-05-2025
11-25-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$351,000.00
$1,372,022,139.00
Revenue This Year
N/A
$5.92
Revenue Next Year
N/A
$3.80
P/E Ratio
$28.23
N/A
Revenue Growth
N/A
6.08
52 Week Low
$6.53
$2.12
52 Week High
$29.98
$4.88

Technical Indicators

Market Signals
Indicator
MCRB
BZUN
Relative Strength Index (RSI) 49.93 44.10
Support Level $16.61 $2.73
Resistance Level $18.86 $2.95
Average True Range (ATR) 3.42 0.13
MACD -0.19 0.02
Stochastic Oscillator 11.70 71.05

Price Performance

Historical Comparison
MCRB
BZUN

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

Share on Social Networks: